The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. [electronic resource]
Producer: 20110303Description: 180-6 p. digitalISSN:- 1559-0100
- Aged
- Alendronate -- adverse effects
- Alkaline Phosphatase -- metabolism
- Bone Density Conservation Agents -- adverse effects
- Cell Differentiation -- drug effects
- Cell Survival -- drug effects
- Cells, Cultured
- Gene Expression Regulation -- drug effects
- Humans
- Middle Aged
- Osmolar Concentration
- Osteoblasts -- drug effects
- Osteocalcin -- genetics
- Osteoporosis -- drug therapy
- Osteoprotegerin -- genetics
- RANK Ligand -- genetics
- RNA, Messenger -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Time Factors
- Vitamin D -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.